Last 12 months
Inside the activity.
0 purchase rows · 16 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 7 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 5 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 2 |
| Jul 2026 | 0 | 1 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 1 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| August 03, 2020 Filed Aug 5, 2020 17:11 UTC |
TEN HOEDT ROBEVP & President EMEA
|
GrantStock Option (Right to Buy) · Derivative | 42,191 | $0.00 Strike: $97.33 | $0.00 |
DisclosureSEC source: 0001127602-20-022926 · form4.xml · derivative · entry 4 TEN HOEDT ROB · CIK 0001610036 · EVP & President EMEA 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 42,191 Underlying: Ordinary Shares · 42,191 shares Expires 2030-08-03 F2 · derivative.exercise_date: These options become exercisable at the rate of 25% of the shares granted per year beginning on the first anniversary of grant. Read SEC document |
| August 03, 2020 Filed Aug 5, 2020 17:11 UTC |
TEN HOEDT ROBEVP & President EMEA
|
GrantStock Option (Right to Buy) · Derivative | 1,575 | $0.00 Strike: $97.33 | $0.00 |
DisclosureSEC source: 0001127602-20-022926 · form4.xml · derivative · entry 3 TEN HOEDT ROB · CIK 0001610036 · EVP & President EMEA 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,575 Underlying: Ordinary Shares · 1,575 shares Expires 2030-08-03 F2 · derivative.exercise_date: These options become exercisable at the rate of 25% of the shares granted per year beginning on the first anniversary of grant. Read SEC document |
| August 03, 2020 Filed Aug 5, 2020 17:11 UTC |
TEN HOEDT ROBEVP & President EMEA
|
GrantStock Option (Right to Buy) · Derivative | 52,896 | $0.00 Strike: $97.33 | $0.00 |
DisclosureSEC source: 0001127602-20-022926 · form4.xml · derivative · entry 2 TEN HOEDT ROB · CIK 0001610036 · EVP & President EMEA 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 52,896 Underlying: Ordinary Shares · 52,896 shares Expires 2030-08-03 F2 · derivative.exercise_date: These options become exercisable at the rate of 25% of the shares granted per year beginning on the first anniversary of grant. Read SEC document |
| August 03, 2020 Filed Aug 5, 2020 17:11 UTC |
TEN HOEDT ROBEVP & President EMEA
|
GrantOrdinary Shares | 5,754 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-20-022926 · form4.xml · nonDerivative · entry 1 TEN HOEDT ROB · CIK 0001610036 · EVP & President EMEA 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 62,623 F1 · kind: The restrictions on these restricted stock units shall lapse 100% on the third anniversary of the Grant Date. Read SEC document |
| August 03, 2020 Filed Aug 5, 2020 21:06 UTC |
Salmon SeanEVP & Group President Diabetes
|
GrantStock Option (Right to Buy) · Derivative | 30,227 | $0.00 Strike: $97.33 | $0.00 |
DisclosureSEC source: 0001127602-20-022918 · form4.xml · derivative · entry 4 Salmon Sean · CIK 0001792380 · EVP & Group President Diabetes 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,227 Underlying: Ordinary Shares · 30,227 shares Expires 2030-08-03 F2 · derivative.exercise_date: These options become exercisable at the rate of 25% of the shares granted per year beginning on the first anniversary of grant. Read SEC document |
| August 03, 2020 Filed Aug 5, 2020 21:06 UTC |
Salmon SeanEVP & Group President Diabetes
|
GrantStock Option (Right to Buy) · Derivative | 1,575 | $0.00 Strike: $97.33 | $0.00 |
DisclosureSEC source: 0001127602-20-022918 · form4.xml · derivative · entry 3 Salmon Sean · CIK 0001792380 · EVP & Group President Diabetes 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,575 Underlying: Ordinary Shares · 1,575 shares Expires 2030-08-03 F2 · derivative.exercise_date: These options become exercisable at the rate of 25% of the shares granted per year beginning on the first anniversary of grant. Read SEC document |
| August 03, 2020 Filed Aug 5, 2020 21:06 UTC |
Salmon SeanEVP & Group President Diabetes
|
GrantStock Option (Right to Buy) · Derivative | 45,340 | $0.00 Strike: $97.33 | $0.00 |
DisclosureSEC source: 0001127602-20-022918 · form4.xml · derivative · entry 2 Salmon Sean · CIK 0001792380 · EVP & Group President Diabetes 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 45,340 Underlying: Ordinary Shares · 45,340 shares Expires 2030-08-03 F2 · derivative.exercise_date: These options become exercisable at the rate of 25% of the shares granted per year beginning on the first anniversary of grant. Read SEC document |
| August 03, 2020 Filed Aug 5, 2020 21:06 UTC |
Salmon SeanEVP & Group President Diabetes
|
GrantOrdinary Shares | 4,932 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-20-022918 · form4.xml · nonDerivative · entry 1 Salmon Sean · CIK 0001792380 · EVP & Group President Diabetes 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 28,041 F1 · kind: The restrictions on these restricted stock units shall lapse 100% on the third anniversary of the Grant Date. Read SEC document |
| July 31, 2020 Filed Aug 3, 2020 17:48 UTC |
Liddicoat John REVP & President of Americas
|
Tax withholdingOrdinary Shares | 2,269 | $96.48 | $218,913.12 |
DisclosureSEC source: 0001127602-20-022598 · form4.xml · nonDerivative · entry 1 Liddicoat John R · CIK 0001752060 · EVP & President of Americas 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 37,922 F1 · balance_after: This balance increased by 1,080 shares due to exempt transactions such as dividend reinvestment and employee stock purchase plan. Read SEC document |
| July 31, 2020 Filed Aug 3, 2020 18:11 UTC |
WHITE ROBERT JOHNEVP & President MITG
|
Tax withholdingOrdinary Shares | 2,727 | $96.48 | $263,100.96 |
DisclosureSEC source: 0001127602-20-022617 · form4.xml · nonDerivative · entry 1 WHITE ROBERT JOHN · CIK 0001726709 · EVP & President MITG 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 50,094 F1 · balance_after: This balance increased by 753 shares due to exempt transactions such as dividend reinvestment and employee stock purchase plan. Read SEC document |
| July 31, 2020 Filed Aug 3, 2020 18:02 UTC |
Surface Carol ASVP, Chief HR Officer
|
Tax withholdingOrdinary Shares | 3,554 | $96.48 | $342,889.92 |
DisclosureSEC source: 0001127602-20-022608 · form4.xml · nonDerivative · entry 1 Surface Carol A · CIK 0001485966 · SVP, Chief HR Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 44,313 F1 · balance_after: This balance increased by 424 shares due to exempt transactions such as dividend reinvestment and employee stock purchase plan. Read SEC document |
| July 31, 2020 Filed Aug 3, 2020 22:08 UTC |
Wall Brett A.EVP & Group Pres Restora Thera
|
Tax withholdingOrdinary Shares | 1,100 | $96.48 | $106,128.00 |
DisclosureSEC source: 0001127602-20-022613 · form4.xml · nonDerivative · entry 1 Wall Brett A. · CIK 0001473812 · EVP & Group Pres Restora Thera 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,280 F1 · balance_after: This balance increased by 205 shares due to exempt transactions such as dividend reinvestment. Read SEC document |
| July 31, 2020 Filed Aug 3, 2020 21:33 UTC |
COYLE MICHAEL JEVP & Group Pres, Cardiac&Vasc
|
Tax withholdingOrdinary Shares | 7,922 | $96.48 | $764,314.56 |
DisclosureSEC source: 0001127602-20-022588 · form4.xml · nonDerivative · entry 1 COYLE MICHAEL J · CIK 0001233311 · EVP & Group Pres, Cardiac&Vasc 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 181,110 F1 · balance_after: This balance increased by 770 shares due to exempt transactions such as dividend reinvestment. Read SEC document |
| July 31, 2020 Filed Aug 3, 2020 21:43 UTC |
Kuntz RichardSVP & Chief Medical & Science
|
Tax withholdingOrdinary Shares | 4,482 | $96.48 | $432,423.36 |
DisclosureSEC source: 0001127602-20-022592 · form4.xml · nonDerivative · entry 1 Kuntz Richard · CIK 0001341125 · SVP & Chief Medical & Science 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 67,425 F1 · balance_after: This balance increased by 894 shares due to exempt transactions such as dividend reinvestment. Read SEC document |
| July 31, 2020 Filed Aug 3, 2020 21:37 UTC |
ISHRAK OMARDirector · Executive Chairman
|
Tax withholdingOrdinary Shares | 26,082 | $96.48 | $2,516,391.36 |
DisclosureSEC source: 0001127602-20-022589 · form4.xml · nonDerivative · entry 1 ISHRAK OMAR · CIK 0001523102 · Director · Executive Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 561,795 F1 · balance_after: This balance increased by 2,888 shares due to exempt transactions such as dividend reinvestment and employee stock purchase plan. Read SEC document |
| July 31, 2020 Filed Aug 3, 2020 21:55 UTC |
PARKHILL KAREN LEVP & Chief Financial Officer
|
Tax withholdingOrdinary Shares | 6,339 | $96.48 | $611,586.72 |
DisclosureSEC source: 0001127602-20-022603 · form4.xml · nonDerivative · entry 1 PARKHILL KAREN L · CIK 0001527660 · EVP & Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 79,026 F1 · balance_after: This balance increased by 255 shares due to exempt transactions such as dividend reinvestment. Read SEC document |
| July 31, 2020 Filed Aug 3, 2020 21:46 UTC |
Lerman Bradley ESVP General Counsel & Corp Sec
|
Tax withholdingOrdinary Shares | 5,411 | $96.48 | $522,053.28 |
DisclosureSEC source: 0001127602-20-022596 · form4.xml · nonDerivative · entry 1 Lerman Bradley E · CIK 0001559405 · SVP General Counsel & Corp Sec 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 46,208 F1 · balance_after: This balance increased by 817 shares due to exempt transactions such as dividend reinvestment and employee stock purchase plan. Read SEC document |
| July 31, 2020 Filed Aug 3, 2020 21:52 UTC |
Martha GeoffreyDirector · CEO
|
Tax withholdingOrdinary Shares | 4,252 | $96.48 | $410,232.96 |
DisclosureSEC source: 0001127602-20-022601 · form4.xml · nonDerivative · entry 1 Martha Geoffrey · CIK 0001560409 · Director · CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 57,976 F1 · balance_after: This balance increased by 692 shares due to exempt transactions such as dividend reinvestment. Read SEC document |
| July 31, 2020 Filed Aug 3, 2020 18:06 UTC |
TEN HOEDT ROBEVP & President EMEA
|
Tax withholdingOrdinary Shares | 3,677 | $96.48 | $354,756.96 |
DisclosureSEC source: 0001127602-20-022611 · form4.xml · nonDerivative · entry 1 TEN HOEDT ROB · CIK 0001610036 · EVP & President EMEA 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 56,869 F1 · balance_after: This balance increased by 594 shares due to exempt transactions such as dividend reinvestment. Read SEC document |
| July 31, 2020 Filed Aug 3, 2020 21:59 UTC |
Salmon SeanEVP & Group President Diabetes
|
Tax withholdingOrdinary Shares | 2,569 | $96.48 | $247,857.12 |
DisclosureSEC source: 0001127602-20-022606 · form4.xml · nonDerivative · entry 1 Salmon Sean · CIK 0001792380 · EVP & Group President Diabetes 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,109 F1 · balance_after: This balance increased by 269 shares due to exempt transactions such as dividend reinvestment. Read SEC document |
| June 30, 2020 Filed Jul 2, 2020 21:31 UTC |
ISHRAK OMARDirector · Executive Chairman
|
GiftOrdinary Shares | 22,508 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-20-021037 · form4.xml · nonDerivative · entry 2 ISHRAK OMAR · CIK 0001523102 · Director · Executive Chairman 10b5-1 filing: Not disclosed Ownership: Indirect · 2020 GRAT Disclosed balance after: 22,508 Read SEC document |
| June 30, 2020 Filed Jul 2, 2020 21:31 UTC |
ISHRAK OMARDirector · Executive Chairman
|
GiftOrdinary Shares | 22,508 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-20-021037 · form4.xml · nonDerivative · entry 1 ISHRAK OMAR · CIK 0001523102 · Director · Executive Chairman 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 584,989 F1 · balance_after: This balance increased by 2,307 shares due to exempt transactions such as dividend reinvestment. Read SEC document |
| June 01, 2020 Filed Jun 5, 2020 20:33 UTC |
PARKHILL KAREN LEVP & Chief Financial Officer
|
GiftOrdinary Shares | 305 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-20-019008 · form4.xml · nonDerivative · entry 6 PARKHILL KAREN L · CIK 0001527660 · EVP & Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Indirect · By Child #3 Disclosed balance after: 605 Read SEC document |
| June 01, 2020 Filed Jun 5, 2020 20:33 UTC |
PARKHILL KAREN LEVP & Chief Financial Officer
|
GiftOrdinary Shares | 305 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-20-019008 · form4.xml · nonDerivative · entry 5 PARKHILL KAREN L · CIK 0001527660 · EVP & Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 85,110 Read SEC document |
| June 01, 2020 Filed Jun 5, 2020 20:33 UTC |
PARKHILL KAREN LEVP & Chief Financial Officer
|
GiftOrdinary Shares | 305 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-20-019008 · form4.xml · nonDerivative · entry 4 PARKHILL KAREN L · CIK 0001527660 · EVP & Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Indirect · By Child #2 Disclosed balance after: 605 Read SEC document |
| June 01, 2020 Filed Jun 5, 2020 20:33 UTC |
PARKHILL KAREN LEVP & Chief Financial Officer
|
GiftOrdinary Shares | 305 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-20-019008 · form4.xml · nonDerivative · entry 3 PARKHILL KAREN L · CIK 0001527660 · EVP & Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 85,415 Read SEC document |
| June 01, 2020 Filed Jun 5, 2020 20:33 UTC |
PARKHILL KAREN LEVP & Chief Financial Officer
|
GiftOrdinary Shares | 305 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-20-019008 · form4.xml · nonDerivative · entry 2 PARKHILL KAREN L · CIK 0001527660 · EVP & Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Indirect · By Child #1 Disclosed balance after: 605 Read SEC document |
| June 01, 2020 Filed Jun 5, 2020 20:33 UTC |
PARKHILL KAREN LEVP & Chief Financial Officer
|
GiftOrdinary Shares | 305 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-20-019008 · form4.xml · nonDerivative · entry 1 PARKHILL KAREN L · CIK 0001527660 · EVP & Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 85,720 F1 · balance_after: This balance increased by 633 shares due to exempt transactions such as dividend reinvestment. Read SEC document |
| May 29, 2020 Filed Jun 2, 2020 17:39 UTC |
Surface Carol ASVP, Chief HR Officer
|
SaleOrdinary Shares | 2,000 | $97.72 | $195,440.00 |
DisclosureSEC source: 0001127602-20-018500 · form4.xml · nonDerivative · entry 1 Surface Carol A · CIK 0001485966 · SVP, Chief HR Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 47,443 F1 · balance_after: This balance increased by 371 shares due to exempt transactions such as dividend reinvestment. Read SEC document |
| April 29, 2020 Filed Apr 30, 2020 18:41 UTC |
OLEARY DENISE MDirector
|
Tax withholdingOrdinary Shares | 393 | $99.14 | $38,962.02 |
DisclosureSEC source: 0001127602-20-014923 · form4.xml · nonDerivative · entry 1 OLEARY DENISE M · CIK 0001145159 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 67,135 Read SEC document |
| April 29, 2020 Filed Apr 30, 2020 22:45 UTC |
Powell Kendall JDirector
|
Tax withholdingOrdinary Shares | 393 | $99.14 | $38,962.02 |
DisclosureSEC source: 0001127602-20-014924 · form4.xml · nonDerivative · entry 1 Powell Kendall J · CIK 0001298823 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 34,064 Read SEC document |
| April 29, 2020 Filed Apr 30, 2020 22:21 UTC |
DONNELLY SCOTT CDirector
|
Tax withholdingOrdinary Shares | 393 | $99.14 | $38,962.02 |
DisclosureSEC source: 0001127602-20-014916 · form4.xml · nonDerivative · entry 1 DONNELLY SCOTT C · CIK 0001233158 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,358 Read SEC document |
| April 29, 2020 Filed Apr 30, 2020 22:15 UTC |
ARNOLD CRAIGDirector
|
Tax withholdingOrdinary Shares | 393 | $99.14 | $38,962.02 |
DisclosureSEC source: 0001127602-20-014915 · form4.xml · nonDerivative · entry 1 ARNOLD CRAIG · CIK 0001188578 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 32,009 Read SEC document |
| April 29, 2020 Filed Apr 30, 2020 18:33 UTC |
Lenehan James TDirector
|
Tax withholdingOrdinary Shares | 393 | $99.14 | $38,962.02 |
DisclosureSEC source: 0001127602-20-014921 · form4.xml · nonDerivative · entry 1 Lenehan James T · CIK 0001189009 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 56,427 Read SEC document |
| April 29, 2020 Filed Apr 30, 2020 22:29 UTC |
HOGAN RANDALL JDirector
|
Tax withholdingOrdinary Shares | 393 | $99.14 | $38,962.02 |
DisclosureSEC source: 0001127602-20-014920 · form4.xml · nonDerivative · entry 1 HOGAN RANDALL J · CIK 0001189049 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 38,535 Read SEC document |
| April 29, 2020 Filed Apr 30, 2020 22:12 UTC |
ANDERSON RICHARD HDirector
|
Tax withholdingOrdinary Shares | 393 | $99.14 | $38,962.02 |
DisclosureSEC source: 0001127602-20-014914 · form4.xml · nonDerivative · entry 1 ANDERSON RICHARD H · CIK 0001200334 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 96,881 Read SEC document |
| April 29, 2020 Filed Apr 30, 2020 22:38 UTC |
NABEL ELIZABETH GDirector
|
Tax withholdingOrdinary Shares | 393 | $99.14 | $38,962.02 |
DisclosureSEC source: 0001127602-20-014922 · form4.xml · nonDerivative · entry 1 NABEL ELIZABETH G · CIK 0001619929 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,408 Read SEC document |
| April 29, 2020 Filed Apr 30, 2020 22:26 UTC |
Goldsmith Andrea JoDirector
|
Tax withholdingOrdinary Shares | 51 | $99.14 | $5,056.14 |
DisclosureSEC source: 0001127602-20-014918 · form4.xml · nonDerivative · entry 1 Goldsmith Andrea Jo · CIK 0001730514 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,949 Read SEC document |
| April 27, 2020 Filed Apr 29, 2020 18:30 UTC |
OLEARY DENISE MDirector
|
GrantOrdinary Shares | 1,737 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-20-014692 · form4.xml · nonDerivative · entry 1 OLEARY DENISE M · CIK 0001145159 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 67,528 F1 · kind: This restricted stock unit award will vest on the one year anniversary of the grant date. F2 · balance_after: This balance increased by 176 shares due to exempt transactions such as dividend reinvestment. Read SEC document |
| April 27, 2020 Filed Apr 29, 2020 22:33 UTC |
Powell Kendall JDirector
|
GrantOrdinary Shares | 1,737 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-20-014693 · form4.xml · nonDerivative · entry 1 Powell Kendall J · CIK 0001298823 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 34,457 F1 · kind: This restricted stock unit award will vest on the one year anniversary of the grant date. F2 · balance_after: This balance increased by 473 shares due to exempt transactions such as dividend reinvestment. Read SEC document |
| April 27, 2020 Filed Apr 29, 2020 22:03 UTC |
DONNELLY SCOTT CDirector
|
GrantOrdinary Shares | 1,737 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-20-014686 · form4.xml · nonDerivative · entry 1 DONNELLY SCOTT C · CIK 0001233158 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,751 F1 · kind: This restricted stock unit award will vest on the one year anniversary of the grant date. F2 · balance_after: This balance increased by 84 shares due to exempt transactions such as dividend reinvestment. Read SEC document |
| April 27, 2020 Filed Apr 29, 2020 22:00 UTC |
ARNOLD CRAIGDirector
|
GrantOrdinary Shares | 1,737 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-20-014685 · form4.xml · nonDerivative · entry 1 ARNOLD CRAIG · CIK 0001188578 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 32,402 F1 · kind: This restricted stock unit award will vest on the one year anniversary of the grant date. F2 · balance_after: This balance increased by 41 shares due to exempt transactions such as dividend reinvestment. Read SEC document |
| April 27, 2020 Filed Apr 29, 2020 18:24 UTC |
Lenehan James TDirector
|
GrantOrdinary Shares | 1,737 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-20-014690 · form4.xml · nonDerivative · entry 1 Lenehan James T · CIK 0001189009 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 56,820 F1 · kind: This restricted stock unit award will vest on the one year anniversary of the grant date. F2 · balance_after: This balance increased by 363 shares due to exempt transactions such as dividend reinvestment. Read SEC document |
| April 27, 2020 Filed Apr 29, 2020 22:17 UTC |
HOGAN RANDALL JDirector
|
GrantOrdinary Shares | 1,737 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-20-014688 · form4.xml · nonDerivative · entry 1 HOGAN RANDALL J · CIK 0001189049 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 38,928 F1 · kind: This restricted stock unit award will vest on the one year anniversary of the grant date. F2 · balance_after: This balance increased by 41 shares due to exempt transactions such as dividend reinvestment. Read SEC document |
| April 27, 2020 Filed Apr 29, 2020 21:54 UTC |
ANDERSON RICHARD HDirector
|
GrantOrdinary Shares | 1,737 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-20-014684 · form4.xml · nonDerivative · entry 1 ANDERSON RICHARD H · CIK 0001200334 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 97,274 F1 · kind: This restricted stock unit award will vest on the one year anniversary of the grant date. F2 · balance_after: This balance increased by 306 shares due to exempt transactions such as dividend reinvestment. Read SEC document |
| April 27, 2020 Filed Apr 29, 2020 22:27 UTC |
NABEL ELIZABETH GDirector
|
GrantOrdinary Shares | 1,737 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-20-014691 · form4.xml · nonDerivative · entry 1 NABEL ELIZABETH G · CIK 0001619929 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,801 F1 · kind: This restricted stock unit award will vest on the one year anniversary of the grant date. F2 · balance_after: This balance increased by 41 shares due to exempt transactions such as dividend reinvestment. Read SEC document |
| April 27, 2020 Filed Apr 29, 2020 22:21 UTC |
LEAVITT MICHAEL ODirector
|
GrantOrdinary Shares | 1,737 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-20-014689 · form4.xml · nonDerivative · entry 1 LEAVITT MICHAEL O · CIK 0001536118 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 20,243 F1 · kind: This restricted stock unit award will vest on the one year anniversary of the grant date. F2 · balance_after: This balance increased by 195 shares due to exempt transactions such as dividend reinvestment. Read SEC document |
| April 27, 2020 Filed Apr 29, 2020 22:06 UTC |
Goldsmith Andrea JoDirector
|
GrantOrdinary Shares | 1,737 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-20-014687 · form4.xml · nonDerivative · entry 1 Goldsmith Andrea Jo · CIK 0001730514 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,000 F1 · kind: This restricted stock unit award will vest on the one year anniversary of the grant date. F2 · balance_after: This balance increased by 4 shares due to exempt transactions such as dividend reinvestment. Read SEC document |
| April 03, 2020 Filed Apr 7, 2020 18:17 UTC |
OLEARY DENISE MDirector
|
Exercise / conversionStock Option (Right to Buy) · Derivative | 1,813 | $0.00 Strike: $44.13 | $0.00 |
DisclosureSEC source: 0001127602-20-013435 · form4.xml · derivative · entry 3 OLEARY DENISE M · CIK 0001145159 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Ordinary Shares · 1,813 shares Expires 2020-05-03 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_date: This option to purchase 1,813 New Medtronic ordinary shares for $44.13 per share, which was fully vested at the effective time of the Merger, was received in the Merger and represents the conversion of 1,813 Medtronic common stock shares for $44.13 per share. This New Medtronic stock option has the same terms and conditions as the original Medtronic stock option. Read SEC document |
| April 03, 2020 Filed Apr 7, 2020 18:17 UTC |
OLEARY DENISE MDirector
|
Tax withholdingOrdinary Shares | 929 | $86.27 | $80,144.83 |
DisclosureSEC source: 0001127602-20-013435 · form4.xml · nonDerivative · entry 2 OLEARY DENISE M · CIK 0001145159 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 65,615 Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.